What sector does Virax Biolabs Group Limited Ordinary Shares (VRAX) operate in?
Virax Biolabs Group Limited Ordinary Shares belongs to the Healthcare sector and operates in the Biotechnology industry.
What is Virax Biolabs Group Limited Ordinary Shares (VRAX) current stock price?
As of the latest data, Virax Biolabs Group Limited Ordinary Shares stock price is $0.23, with a previous close of $0.20. Virax Biolabs Group Limited Ordinary Shares gained $0.03 in the last trading session, representing a 12.5% increase.
What is Virax Biolabs Group Limited Ordinary Shares (VRAX) current market capitalization?
Virax Biolabs Group Limited Ordinary Shares market cap is approximately 1.67 million.
What is Virax Biolabs Group Limited Ordinary Shares (VRAX) Earnings Per Share (EPS)?
The trailing EPS is -$1.22, and the forward EPS is -$1.01.
What is Virax Biolabs Group Limited Ordinary Shares (VRAX) EBITDA?
Virax Biolabs Group Limited Ordinary Shares EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -2.37 million.
Does Virax Biolabs Group Limited Ordinary Shares (VRAX) pay dividends?
No. Virax Biolabs Group Limited Ordinary Shares does not pay a dividend.
What is Virax Biolabs Group Limited Ordinary Shares (VRAX) beta (volatility) score?
Virax Biolabs Group Limited Ordinary Shares has a beta of 1.658, suggesting it is more volatile than the market.